It’s a great news for Brittany biotechnologies domain. Biotrial opens a new site in USA to grow up its capacity for phase 1 studies. The Newark site will perform up to 50 studies per year ! Congratulation Biotrial.

According to Francois Peaucelle, General Manager, Biotrial, the company has started activities with studies for European and American biotech, the pharma industry, and US generics companies.

Source: Biotrial: transparency key as CRO moves forward in US